Browsing Tag
Freenome
2 posts
Can Freenome’s $1.1bn SPAC deal unlock a new chapter for blood-based multi-cancer detection?
Freenome merges with PCSC in $1.1B deal to go public as FRNM. Find out how its AI-powered blood tests could change early cancer detection.
The business of AI in oncology: Who’s building the platforms hospitals trust?
Tempus, Guardant, Freenome, and Paige are building the AI oncology platforms hospitals now rely on. Discover the financials and future shaping cancer diagnostics.